Guanidine hydrochloride in the Eaton-Lambert syndrome. Electrophysiologic improvement.
D000200:Action Potentials; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D002277:Carcinoma / Q000188:drug therapy / Q000503:physiopathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004576:Electromyography; D006146:Guanidines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology; D009135:Muscular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D009431:Neural Conduction; D010525:Peripheral Nerves / Q000503:physiopathology; D009435:Synaptic Transmission; D013577:Syndrome
D006146:Guanidines; D003520:Cyclophosphamide